Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2025 (33)
  • 2024 (40)
  • 2023 (73)
  • 2022 (54)
  • 2021 (32)
  • 2020 (8)
  • 2019 (2)

Subject

  • Drug Trafficking (4010)
  • Synthetic drugs (1064)
  • Guns/Weapons (989)
  • OCDETF/Task Force (810)
  • Fake Pills (654)
  • Arrests/Convictions - Major (603)
  • Guilty Plea (529)
  • Seizures (Drugs/Property) (456)
  • Prescription Drugs (364)
  • Overdose (321)
  • Major Law Enforcement Operation (267)
  • Take Back Day (246)
  • Task Forces/Task Force Officers (230)
  • Pharmaceuticals/Pharmacists/Physicians (224)
  • Money Laundering (203)
  • Gangs (196)
  • Outreach/Drug Prevention (184)
  • Fentanyl Awareness (152)
  • One Pill Can Kill (110)
  • HIDTA (103)
  • Press Conferences (68)
  • Narcoterrorism (53)
  • Prevention/Education - DEA websites GSAD, JTT etc (53)
  • Extraditions (50)
  • Public and Media Affairs - also see Congressional Affairs (50)
  • Dark Web- Internet Trafficking (29)
  • Asset Forfeiture (28)
  • International/Foreign Operations (28)
  • Red Ribbon (27)
  • Congressional Affairs (15)
  • Terrorism (14)
  • Fentanyl Free America (12)
  • Intergovernmental Affairs (9)
  • Other (8)
  • Campaigns (7)
  • Critical Incident (6)
  • Counterfeit Pills (5)
  • Intelligence Division - Intelligence Products (5)
  • Scam Calls (5)
  • Museum and Visitors Center (3)
  • El Paso Intelligence Center (2)
  • Recruitment/Office of Training/Graduations (2)
  • Diversion Division (242)

Drug Name

  • Opioids (42)
  • Oxycodone (37)
  • Fentanyl (28)
  • Hydromorphone (13)
  • Synthetic Opioids (10)
  • Benzodiazepines (7)
  • Methamphetamine (6)
  • Morphine (6)
  • Amphetamines (3)
  • Methadone (3)
  • Steroids (3)
  • Cocaine (2)
  • Heroin (2)
  • Marijuana (Cannabis) (2)
  • Ketamine (1)
  • Marijuana Concentrates (1)

Field Division

  • Washington, DC (34)
  • New England (33)
  • New York (23)
  • Seattle (22)
  • Chicago (18)
  • Houston (15)
  • New Jersey (14)
  • Atlanta (13)
  • Miami (9)
  • New Orleans (8)
  • Sede (8)
  • San Francisco (7)
  • St. Louis (7)
  • El Paso (6)
  • Dallas (5)
  • Rocky Mountain (5)
  • Los Angeles (3)
  • Omaha (3)
  • Phoenix (3)
  • San Diego (3)
  • Louisville (2)
  • Detroit (1)
Clear All Results
PRESS RELEASE

Dark Web Vendor of Opioids and Counterfeit U.S. Currency Pleads Guilty

Mayo 12, 2021
ALEXANDRIA, Va. – A Utica, New York man pleaded guilty yesterday to charges relating to his sale of over $1.2 million in opioid pills and counterfeit U.S. currency on multiple dark web criminal marketplaces. According to court documents, from around October 2016 through February 2021, Albie Pagan, 65, operated under...
Mayo 12, 2021
PRESS RELEASE

DEA 2020 Year in Review: Combatting Serious Drug-Related Threats During the Pandemic

Enero 14, 2021
WASHINGTON – With the unprecedented worldwide health emergency brought on by COVID-19, last year was filled with new challenges and increased risks. While much of the world focused on combating the pandemic, DEA continued to implement initiatives to combat violent drug traffickers who were intent on flooding cities and rural...
Enero 14, 2021
PRESS RELEASE

Odessa pharmacy and owner to pay $320,000 in civil penalties

Diciembre 02, 2020
EL PASO, Texas -- Odessa pharmacy Town & Country Drug, Inc. (Town & Country) and its owner, pharmacist Gary Warren, have entered into a civil settlement with the United States that requires them to pay $320,000 in civil penalties to resolve allegations that they violated certain provisions of the Controlled...
Diciembre 02, 2020
PRESS RELEASE

DEA implements ecommerce outreach program to combat counterfeit drug production

Agosto 04, 2020
WASHINGTON – The U.S. Drug Enforcement Administration has developed an e-commerce outreach program aimed at reducing the availability of dangerous, often deadly, counterfeit prescription drugs in the United States. This DEA-led initiative focuses on educating online retailers about the sale of pill presses and components used in the production of...
Agosto 04, 2020
PRESS RELEASE

DEA St. Louis Division launches website for community resources

Junio 02, 2020
ST. LOUIS – Unintended consequences of social distancing and isolation throughout the COVID-19 pandemic can include increased substance use, experimentation and even relapse for those in treatment and recovery. To help people find support facilities, the Drug Enforcement Administration St. Louis Division, along with community partners, has launched a website...
Junio 02, 2020
PRESS RELEASE

Omnicare Inc. agrees to pay more than $15 million to resolve allegations it improperly dispensed narcotics at long-term care facilities

Mayo 13, 2020
WASHINGTON – Omnicare Inc., a subsidiary of CVS Health and a leading provider of pharmacy services to long-term care facilities, has agreed to pay the United States a $15.3 million civil penalty to resolve allegations that it violated federal law by allowing opioids and other controlled substances to be dispensed...
Mayo 13, 2020
PRESS RELEASE

Omnicare agrees to pay over $15 Million to resolve allegations it improperly dispensed opioids at long-term care facilities

Mayo 13, 2020
PORTLAND, Ore.—Omnicare Inc., a subsidiary of CVS Health and a provider of pharmacy services to long-term care facilities, has agreed to pay the United States a $15.3 million civil penalty to resolve allegations that it violated federal law by, among other things, allowing opioids and other controlled substances to be...
Mayo 13, 2020
PRESS RELEASE

Wisconsin physician agrees to pay penalties to resolve allegations of prescribing opioids illegally and violating False Claims Act

Abril 06, 2020
MILWAUKEE - DEA Assistant Special Agent in Charge Paul E. Maxwell and United States Attorney Matthew D. Krueger announced today that Dr. Mehran Heydarpour of Brookfield, Wisconsin, agreed to pay $175,000 to resolve allegations that he prescribed opioid pain medications in violation of the Controlled Substances Act and that he...
Abril 06, 2020
PRESS RELEASE

St. Louis County doctor pleads guilty to fraudulently obtaining opioid narcotic prescription drugs

Enero 21, 2020
ST. LOUIS – Angela K. Williams, M.D., 34, of Brentwood, Missouri, pleaded guilty today to one felony charge of fraudulently obtaining oxycodone, a narcotic opioid prescription drug. This case was investigated by the Drug Enforcement Administration St. Louis Division, the Florissant Police Department, the Town and Country Police Department, and...
Enero 21, 2020
PRESS RELEASE

Champaign man sentenced to 13 years in prison for trafficking

Enero 06, 2020
URBANA, Ill. – U.S. District Judge Michael M. Mihm today sentenced a Champaign, ll., man, Stephan Caamano, to 13 years in federal prison for trafficking at least 4.3 million counterfeit Xanax pills throughout the country and laundering the proceeds. Caamano has been ordered to pay more than $2.1 million he...
Enero 06, 2020
Showing 231 - 240 of 242 results

Paginación

  • Primera página «
  • Página anterior ‹
  • Página 17
  • Página 18
  • Página 19
  • Página 20
  • Página 21
  • Página 22
  • Página 23
  • Current page 24
  • Página 25
  • Siguiente página ›
  • Última página »
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster